Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 236

1.

Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling.

Chen Q, Jin M, Yang F, Zhu J, Xiao Q, Zhang L.

Mediators Inflamm. 2013;2013:928315. doi: 10.1155/2013/928315. Epub 2013 Jun 12. Review.

2.

Role of matrix metalloproteinases in vascular remodeling.

Kuzuya M, Iguchi A.

J Atheroscler Thromb. 2003;10(5):275-82. Review.

3.

Matrix Metalloproteinase 2 as a Potential Mediator of Vascular Smooth Muscle Cell Migration and Chronic Vascular Remodeling in Hypertension.

Belo VA, Guimarães DA, Castro MM.

J Vasc Res. 2015;52(4):221-31. doi: 10.1159/000441621. Epub 2016 Jan 6. Review.

PMID:
26731549
4.

Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases.

Siasos G, Tousoulis D, Kioufis S, Oikonomou E, Siasou Z, Limperi M, Papavassiliou AG, Stefanadis C.

Curr Top Med Chem. 2012;12(10):1132-48. Review.

PMID:
22519444
5.

Matrix metalloproteinases in vascular physiology and disease.

Siefert SA, Sarkar R.

Vascular. 2012 Aug;20(4):210-6. doi: 10.1258/vasc.2011.201202. Epub 2012 Aug 15. Review.

PMID:
22896663
6.

[The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis].

Fink K, Boratyński J.

Postepy Hig Med Dosw (Online). 2012 Sep 10;66:609-28. Review. Polish.

7.

Matrix metalloproteinases: new routes to the use of MT1-MMP as a therapeutic target in angiogenesis-related disease.

Arroyo AG, Genís L, Gonzalo P, Matías-Román S, Pollán A, Gálvez BG.

Curr Pharm Des. 2007;13(17):1787-802. Review.

PMID:
17584108
8.

MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells.

Filippov S, Koenig GC, Chun TH, Hotary KB, Ota I, Bugge TH, Roberts JD, Fay WP, Birkedal-Hansen H, Holmbeck K, Sabeh F, Allen ED, Weiss SJ.

J Exp Med. 2005 Sep 5;202(5):663-71.

9.

Matrix metalloproteinases and angiogenesis.

Rundhaug JE.

J Cell Mol Med. 2005 Apr-Jun;9(2):267-85. Review.

11.

Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions.

Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Libby P.

Ann N Y Acad Sci. 1995 Jan 17;748:501-7.

PMID:
7695193
12.

[Matrix metalloproteinases and atherosclerosis].

Fic P, Zakrocka I, Kurzepa J, Stepulak A.

Postepy Hig Med Dosw (Online). 2011 Jan 25;65:16-27. Review. Polish.

13.

Vascular extracellular matrix in atherosclerosis.

Chistiakov DA, Sobenin IA, Orekhov AN.

Cardiol Rev. 2013 Nov-Dec;21(6):270-88. doi: 10.1097/CRD.0b013e31828c5ced. Review.

PMID:
23422022
14.
16.

Effect of hormones on matrix metalloproteinases gene regulation in human aortic smooth muscle cells.

Grandas OH, Mountain DJ, Kirkpatrick SS, Rudrapatna VS, Cassada DC, Stevens SL, Freeman MB, Goldman MH.

J Surg Res. 2008 Jul;148(1):94-9. doi: 10.1016/j.jss.2008.03.003. Epub 2008 Apr 9.

PMID:
18570937
17.

Matrix metalloproteinases and their role in oncogenesis: a review.

Pytliak M, Vargová V, Mechírová V.

Onkologie. 2012;35(1-2):49-53. doi: 10.1159/000336304. Epub 2012 Jan 23.

PMID:
22310347
19.

Relevance of tenascin-C and matrix metalloproteinases in vascular abnormalities in murine hypoplastic lungs.

Chinoy MR, Miller SA.

Biol Neonate. 2006;90(3):185-96. Epub 2006 May 12.

PMID:
16699260
20.

Extracellular matrix proteases - cytokine regulation role in cancer and pregnancy.

Huang SC, Sheu BC, Chang WC, Cheng CY, Wang PH, Lin S.

Front Biosci (Landmark Ed). 2009 Jan 1;14:1571-88. Review.

PMID:
19273147

Supplemental Content

Support Center